Join Exoma CommunityJoin

Lipotropic Blend 216

Lipotropic Blend 216 mg by EXOMA. COA quality per batch. Ideal for research into lipid metabolism. Shipping 24-72h.

Lipotropic Blend 216: Scientific Profile

Publicado el · Actualizado el

Research formulation that combines L-Carnitine, L-Arginine, Methionine, Inositol, Choline, and B Vitamins. Designed for preclinical studies focused on lipid metabolism and cellular energy transport.

The Lipotropic Blend 216 is a solution composed of lipotropic agents and metabolic precursors intended exclusively for scientific research. This formulation integrates sulfated amino acids such as methionine and quaternary ammonium compounds such as choline, which act synergistically in experimental models to facilitate the export of lipids from the hepatic parenchyma into the bloodstream for subsequent oxidation.

In laboratory settings, the presence of inositol and carnitine has been observed to optimize the translocation of long-chain fatty acids across the inner mitochondrial membrane, a process mediated by the enzyme carnitine palmitoyltransferase I. This interaction is crucial for the analysis of metabolic efficiency and energy expenditure in study subjects under conditions of caloric stress or induced weight-reduction regimens.

In addition, the inclusion of B-complex vitamins in this mixture allows for the investigation of their role as enzymatic cofactors in the Krebs cycle and amino-acid metabolism. Lipotropic Blend 216 is commonly used in protocols that seek to document the preservation of lean mass while optimizing the mobilization of white adipose tissue in animal models and specific cell cultures.

Mechanism of action

The compound operates by upregulating the processes of methylation and fatty acid transport. Choline and inositol act as precursors of phospholipids, essential for the structural integrity of very-low-density lipoproteins (VLDL), facilitating hepatic lipid efflux. In parallel, L-Carnitine acts as the rate-limiting transporter in the carnitine-acyltransferase transport system, allowing fatty acids to enter the mitochondrial matrix for beta-oxidation.

Mechanism summary

Synergy of lipotropic factors that promote mitochondrial transport of fatty acids and the synthesis of lipoproteins for the mobilization of lipid deposits.

Clinical Studies (6)

There is no peer-reviewed literature on Blend Lipotrópico 216 as a combination. What follows is the literature on each component separately:

  • Sobre L-Carnitina: Carnitine transport and fatty acid oxidation. (Longo N, et al. · Biochim Biophys Acta · 2016) PMID 26828774.
  • Sobre L-Arginina: Association of l-Arginine Supplementation with Markers of Endothelial Function in Patients with Cardiovascular or Metabolic Disorders: A Systematic Review and Meta-Analysis. (Rodrigues-Krause J, et al. · Nutrients · 2018) PMID 30577559.
  • Sobre L-Metionina: Dietary methionine restriction increases fat oxidation in obese adults with metabolic syndrome. (Plaisance EP, et al. · J Clin Endocrinol Metab · 2011) PMID 21346062.
  • Sobre Inositol: Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. (Nestler JE, et al. · N Engl J Med · 1999) PMID 10219066.
  • Sobre Colina: Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. (Buchman AL, et al. · JPEN J Parenter Enteral Nutr · 2001) PMID 11531217.
  • Sobre Vitamina B12: Vitamin B12 deficiency (Stabler, et al. · The New England Journal of Medicine · 2013) PMID 23301732.

Warnings

Lipotropic Blend 216 is a research-use-only (RUO) compound; the following warnings and handling considerations apply to its laboratory use:

  • Product exclusively for laboratory research use
  • Requires handling under strict aseptic conditions
  • Monitor renal function in models of prolonged exposure
  • Models with documented chronic renal insufficiency
  • Research subjects with a history of severe arrhythmias
  • Known hypersensitivity to the components of the vehicle
  • Conditions of severe metabolic dehydration

Technical data

Compound type
blend
Storage
-20 °C liofilizado; 2-8 °C reconstituido
Shelf life (lyophilized)
24 months
Shelf life (reconstituted)
30 days refrigerated
Light-sensitive
No

Frequently asked questions about Lipotropic Blend 216

What is Lipotropic Blend 216?

Research formulation that combines L-Carnitine, L-Arginine, Methionine, Inositol, Choline, and B Vitamins. Designed for preclinical studies focused on lipid metabolism and cellular energy transport.

What is the mechanism of action of Lipotropic Blend 216?

Synergy of lipotropic factors that promote mitochondrial transport of fatty acids and the synthesis of lipoproteins for the mobilization of lipid deposits.

What is Lipotropic Blend 216 researched for?

In preclinical research, Blend Lipotrópico 216 is studied mainly in: Research on the acceleration of fatty acid beta-oxidation; Modeling of weight reduction in experimental subjects; Modulation of intrahepatic lipid transport. Material exclusively for scientific research.

How is Lipotropic Blend 216 stored?

Condiciones de conservación: -20 °C liofilizado; 2-8 °C reconstituido; estabilidad liofilizado: 24 meses; una vez reconstituido: 30 días refrigerado.

What routes of administration are studied for Lipotropic Blend 216?

In research models the following are described: Subcutaneous, Intramuscular. Use is exclusively for scientific research.

What precautions should be considered with Lipotropic Blend 216?

Lipotropic Blend 216 is material for research use only. Product for laboratory research use only. It requires handling under strict aseptic conditions.

See also